In addition to these widely used AOMs, Exenatide, one of the earliest GLP-1 RAs approved by the FDA and EMA for T2DM management, is not indicated for weight management but remains clinically relevant, particularly in older adults with comorbid obesity and T2DM, given its long-term clinical experience and established tolerability profile [26,27,28]
"Tom Hanks Just Can't Quit World War II (and It's Keeping Him Up at Night)"
Its important to watch for pancreatitis signs, like severe stomach pain
Others describe difficulty getting refunds for medications that were charged but never shipped
Knowing what to expect can help you adhere to the treatment more effectively Below is an outline of a timeline-based approach of potential side effects and their typical progression: Week 1-4: The Adjustment Period As the body adjusts to GLP-1 therapy, mild to moderate side effects are common during the first few weeks
Why Consistent Follow-Up Matters Progress does not always happen in a straight line